Skip to main content
Fig. 1 | BMC Nutrition

Fig. 1

From: The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study

Fig. 1

Study flow chart. Out of 115 subjects, 24 subjects met the inclusion criteria and were enrolled. All subjects completed the study. Subjects consumed placebo for 4 weeks (day 1 -day 28) and then changed to Pylopass™ containing Lactobacillus reuteri DSM17648 (2 × 1010 cells) from day 29 through day 56. They were blinded as to which product they were receiving

Back to article page

BMC Nutrition

ISSN: 2055-0928

Contact us